Mapping Pathways is a multi-national project to develop and nurture a research-driven, community-led global understanding of the emerging evidence base around the adoption of antiretroviral-based prevention strategies to end the HIV/AIDS epidemic. The evidence base is more than results from clinical trials - it must include stakeholder and community perspectives as well.

14 June 2012

Register today for the Mapping Pathways Community Perspectives on PrEP Webinar!

Tuesday, June 19 at 3:00pm EST

In response to recent news from the FDA regarding the use of the drug Truvada for prevention, Mapping Pathways U.S. partners AIDS United and AIDS Foundation of Chicago are presenting a webinar focusing on the ARV-based strategy PrEP (pre-exposure prophylaxis.)

Please join us Tuesday, June 19th at 3:00 pm EST for this webinar. Email to register.

During the webinar, key findings from the Mapping Pathways online survey and stakeholder interviews will be presented to help illuminate the wide-ranging perspectives of advocates, clinicians, people living with HIV, policy makers and others regarding PrEP. While the U.S. context will be highlighted, comparisons/contrasts will be drawn with the opinions of individuals in South Africa and India.

Following the presentation, a moderated discussion will ask webinar participants to reflect on their particular jurisdictions and to share their own PrEP assessments.

We hope you will be able to join us for this timely conversation.

[Content that is linked from other sources is for informational purposes and should not construe a Mapping Pathways position. Please look for us on Facebook here and you can follow us on Twitter @mappingpathways as well.]

No comments:

Post a Comment